| Title | Cancer Discovery |
| Abbreviation | Cancer Discov. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Oncology (Q1) |
| h-index | 209 |
| Overall Rank/Ranking | 134 |
| SCImago Journal Rank (SJR) | 7.268 |
| Impact Score | 9.34 |
| Publisher | American Association for Cancer Research Inc. |
| Country | United States |
| ISSN | 21598274, 21598290 |
| Best Quartile | Q1 |
| Coverage History | 2011-2022 |
Cancer Discovery is a journal covering the technologies/fields/categories related to Oncology (Q1). It is published by American Association for Cancer Research Inc.. The overall rank of Cancer Discovery is 134. According to SCImago Journal Rank (SJR), this journal is ranked 7.268. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 209. The best quartile for this journal is Q1.
The ISSN of Cancer Discovery journal is 21598274, 21598290. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cancer Discovery is cited by a total of 11668 articles during the last 3 years (Preceding 2022).
The impact score (IS) 2022 of Cancer Discovery is 9.34, which is computed in 2023 as per its definition. Cancer Discovery IS is decreased by a factor of 1.73 and approximate percentage change is -15.63% when compared to preceding year 2021, which shows a falling trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
IS 2022 of Cancer Discovery is 9.34. If the same downward trend persists, impact score may fall in 2023 as well.
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 9.34 |
| 2021 | 11.07 |
| 2020 | 8.84 |
| 2019 | 7.67 |
| 2018 | 7.04 |
| 2017 | 5.96 |
| 2016 | 4.29 |
| 2015 | 4.00 |
| 2014 | 3.78 |
Cancer Discovery has an h-index of 209. It means 209 articles of this journal have more than 209 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Cancer Discovery is 21598274, 21598290. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Cancer Discovery is 134. According to SCImago Journal Rank (SJR), this journal is ranked 7.268. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 7.268 |
| 2021 | 6.084 |
| 2020 | 6.795 |
| 2019 | 7.513 |
| 2018 | 7.751 |
| 2017 | 6.996 |
| 2016 | 5.174 |
| 2015 | 5.819 |
| 2014 | 5.116 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 134 |
| 2021 | 186 |
| 2020 | 174 |
| 2019 | 137 |
| 2018 | 124 |
| 2017 | 168 |
| 2016 | 262 |
| 2015 | 218 |
| 2014 | 272 |
Cancer Discovery is published by American Association for Cancer Research Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 2011-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Cancer Discovery is Cancer Discov.. This abbreviation ('Cancer Discov.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Oncology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
The latest impact index of the Cancer Discovery is 9.34. It's evaluated in the year 2022. The highest and the lowest impact index or impact score of this journal are 11.07 (2021) and 3.78 (2014), respectively, in the last 9 years. Moreover, its average IS is 6.89 in the previous 9 years.
The Cancer Discovery has an SJR (SCImago Journal Rank) of 7.268, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 7.751 in 2018 and the lowest being 5.116 in 2014. Furthermore, the average SJR of the Cancer Discovery over the previous 9-year period stands at 6.89.
The latest h-index of the Cancer Discovery is 209.
The Cancer Discovery is published by the American Association for Cancer Research Inc., with its country of publication being the United States.
The Cancer Discovery is currently ranked 134 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 124 in 2018 and its lowest position of 272 in 2014.
The standard ISO4 abbreviation for the Cancer Discovery is Cancer Discov..
Cancer Discovery is classified as a journal that the American Association for Cancer Research Inc. publishes.
The Cancer Discovery encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Cancer Discovery is assigned the following International Standard Serial Numbers (ISSN): 21598274, 21598290.
The best quartile for the Cancer Discovery is Q1 (2022).
The Cancer Discovery coverage history can be summarized as follows: 2011-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Indian Journal of Plastic Surgery | journal | 16018 | Thieme Medical Publishers Inc. | 37 | 0.65 |
| Historia | journal | 27560 | Universidade Estadual Paulista | 7 | 0.02 |
| Business Strategy Review | journal | 31512 | Wiley-Blackwell Publishing Ltd | 33 | 0.04 |
| Child and Family Social Work | journal | 8628 | Wiley-Blackwell Publishing Ltd | 67 | 2.20 |
| European Surgery - Acta Chirurgica Austriaca | journal | 16873 | Springer Medizin | 23 | 0.58 |
| Tekstilec | trade journal | 19217 | Faculty of Natural Sciences and Engineering, Tekstilec | 14 | 0.73 |
| Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria | journal | 25905 | National Association of Resident Doctors of Nigeria | 25 | 0.00 |
| Journal on Chain and Network Science | journal | 11905 | Wageningen Academic Publishers | 24 | 0.00 |
| Chemical Product and Process Modeling | journal | 20431 | Walter de Gruyter GmbH | 19 | 1.26 |
| Biomarker Insights | journal | 5159 | Libertas Academica Ltd. | 38 | 3.46 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 9.34 |
| 2021 | 11.07 |
| 2020 | 8.84 |
| 2019 | 7.67 |
| 2018 | 7.04 |
| 2017 | 5.96 |
| 2016 | 4.29 |
| 2015 | 4.00 |
| 2014 | 3.78 |
9.34
209
134
7.268
